{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:29:34Z","timestamp":1794349774223,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":54,"publisher":"Springer New York","isbn-type":[{"value":"9780387720043","type":"print"},{"value":"9780387720050","type":"electronic"}],"license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007]]},"DOI":"10.1007\/978-0-387-72005-0_14","type":"book-chapter","created":{"date-parts":[[2007,9,21]],"date-time":"2007-09-21T01:54:28Z","timestamp":1190339668000},"page":"133-144","source":"Crossref","is-referenced-by-count":6,"title":["Intrathymic Selection: New Insight into Tumor Immunology"],"prefix":"10.1007","author":[{"given":"Dmitry B.","family":"Kazansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1182\/blood-2002-02-0525","volume":"101","author":"P.J. Amrolia","year":"2003","unstructured":"Amrolia, P.J., Reid, S.D., Gao, L., Schultheis, B., Dotti, G., Brenner, M.K., Melo, J.V., Goldman, J.M. and Stauss, H.J. (2003) Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity. Blood 101, 1007\u20131014.","journal-title":"Blood"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.immuni.2005.07.005","volume":"23","author":"M.S. Anderson","year":"2005","unstructured":"Anderson, M.S., Venanzi, E.S., Chen, Z., Berzins, S.P., Benoist, C. and Mathis, D. (2005) The cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227\u2013239.","journal-title":"Immunity"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1084\/jem.183.6.2501","volume":"183","author":"D. Brandle","year":"1996","unstructured":"Brandle, D., Brasseur, F., Weynants, P., Boon, T. and Van den Eynde, B. (1996) A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med. 183, 2501\u20132508.","journal-title":"J. Exp. Med."},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/eji.1830210915","volume":"21","author":"V. Cerundolo","year":"1991","unstructured":"Cerundolo, V., Elliott, T., Elvin, J., Bastin, J., Rammensee, H.G. and Townsend, A. (1991) The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur. J. Immunol. 21, 2069\u20132075.","journal-title":"Eur. J. Immunol."},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"8878","DOI":"10.1158\/0008-5472.CAN-06-1450","volume":"66","author":"C.J. Cohen","year":"2006","unstructured":"Cohen, C.J., Zhao, Y., Zheng, Z., Rosenberg, S.A. and Morgan, R.A. (2006) Enhanced antitumor activity of murine-human hybrid T cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR\/CD3 stability. Cancer Res. 66, 8878\u20138886.","journal-title":"Cancer Res."},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1073\/pnas.92.17.7976","volume":"92","author":"P.G. Coulie","year":"1995","unstructured":"Coulie, P.G., Lehmann, F., Lethe, B., Herman, J., Lurquin, C., Andrawiss, M. and Boon, T. (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. U.S.A. 92, 7976\u20137980.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1084\/jem.185.4.695","volume":"185","author":"P. Dubey","year":"1997","unstructured":"Dubey, P., Hendrickson, R.C., Meredith, S.C., Siegel, C.T., Shabanowitz, J., Skipper, J.C., Engelhard, V.H., Hunt, D.F. and Schreiber, H. (1997) The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. J. Exp. Med. 185, 695\u2013705.","journal-title":"J. Exp. Med."},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature02625","volume":"429","author":"G. Egger","year":"2004","unstructured":"Egger, G., Liang, G., Aparicio, A. and Jones, P.A. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457\u2013463.","journal-title":"Nature"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/351290a0","volume":"351","author":"K. Falk","year":"1991","unstructured":"Falk, K., Rotzschke, O. Stevanovic, S., Jung, G. and Rammensee, H.G. (1991a) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290\u2013296.","journal-title":"Nature"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1084\/jem.174.2.425","volume":"174","author":"K. Falk","year":"1991","unstructured":"Falk, K., Rotzschke, O., Deres, K., Metzger, J., Jung, G. and Rammensee, H.G. (1991b) Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 174, 425\u2013434.","journal-title":"J. Exp. Med."},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/348248a0","volume":"348","author":"K. Falk","year":"1990","unstructured":"Falk, K., Rotzschke, O. and Rammensee, H.G. (1990) Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348, 248\u2013251.","journal-title":"Nature"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrc1070","volume":"3","author":"D.W. Felsher","year":"2003","unstructured":"Felsher, D.W. (2003) Cancer revoked: oncogenes as therapeutic targets. Nat. Rev. Cancer 3, 375\u2013380.","journal-title":"Nat. Rev. Cancer"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","volume":"95","author":"L. Gao","year":"2000","unstructured":"Gao, L., Bellantuono, I., Elsasser, A., Marley, S.B., Gordon, M.Y., Goldman, J.M. and Stauss, H.J. (2000) Selective elimination of leukemic CD34+progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 95, 2198\u20132203.","journal-title":"Blood"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0092-8674(92)90227-4","volume":"69","author":"T.V. Golovkina","year":"1992","unstructured":"Golovkina, T.V., Chervonsky, A., Dudley, J.P. and Ross, S.R. (1992) Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69, 637\u2013645.","journal-title":"Cell"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJMra021902","volume":"347","author":"W.C. Hahn","year":"2002","unstructured":"Hahn, W.C. and Weinberg, R.A. (2002) Rules for making human tumor cells. N. Engl. J. Med. 347, 1593\u20131603.","journal-title":"N. Engl. J. Med."},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/1521-4141(200102)31:2<551::AID-IMMU551>3.0.CO;2-P","volume":"31","author":"M. Kalbus","year":"2001","unstructured":"Kalbus, M., Fleckenstein, B.T., Offenhausser, M., Bluggel, M., Melms, A., Meyer, H.E., Rammensee, H.G., Martin, R., Jung, G. and Sommer, N. (2001) Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-As. Eur. J. Immunol. 31, 551\u2013562.","journal-title":"Eur. J. Immunol."},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrg887","volume":"3","author":"E. Li","year":"2002","unstructured":"Li, E. (2002) Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3, 662\u2013673.","journal-title":"Nat. Rev. Genet."},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20050198","volume":"202","author":"N.N. Logunova","year":"2005","unstructured":"Logunova, N.N., Viret, C., Pobezinsky, L.A., Miller, S.A., Kazansky, D.B., Sundberg, J.P. and Chervonsky, A.V. (2005) Restricted MHC-peptide repertoire predisposes to autoimmunity. J. Exp. Med. 202, 73\u201384.","journal-title":"J. Exp. Med."},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/1074-7613(95)90078-0","volume":"2","author":"P.A. Monach","year":"1995","unstructured":"Monach, P.A., Meredith, S.C., Siegel, C.T. and Schreiber, H. (1995) A unique tumor antigen produced by a single amino acid substitution. Immunity 2, 45\u201359.","journal-title":"Immunity"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1073\/pnas.0500357102","volume":"102","author":"E.C. Morris","year":"2005","unstructured":"Morris, E.C., Tsallios, A., Bendle, G.M., Xue, S.A. and Stauss, H.J. (2005) A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection. Proc. Natl. Acad. Sci. U.S.A. 102, 7934\u20137939.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/1521-4141(200208)32:8<2105::AID-IMMU2105>3.0.CO;2-Q","volume":"32","author":"C. Munz","year":"2002","unstructured":"Munz, C., Hofmann, M., Yoshida, K., Moustakas, A.K., Kikutani, H., Stevanovic, S., Papadopoulos, G.K. and Rammensee, H.G. (2002) Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-Ag7. Eur. J. Immunol. 32, 2105\u20132116.","journal-title":"Eur. J. Immunol."},{"key":"14_CR22","first-page":"149","volume":"7","author":"M. Pelleitier","year":"1975","unstructured":"Pelleitier, M. and Montplaisir, S. (1975) The nude mouse: a model of deficient T cell function. Methods Achiev. Exp. Pathol. 7, 149\u2013166.","journal-title":"Methods Achiev. Exp. Pathol."},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.4049\/jimmunol.172.9.5582","volume":"172","author":"Y. Pobezinskaya","year":"2004","unstructured":"Pobezinskaya, Y., Chervonsky, A.V. and Golovkina, T.V. (2004) Initial stages of mammary tumor virus infection are superantigen independent. J. Immunol. 172, 5582\u20135587.","journal-title":"J. Immunol."},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1475-2867-5-25","volume":"5","author":"R.T. Prehn","year":"2005","unstructured":"Prehn, R.T. (2005) On the nature of cancer and why anticancer vaccines don\u2019t work. Cancer Cell Int. 5, 25.","journal-title":"Cancer Cell Int."},{"key":"14_CR25","first-page":"769","volume":"18","author":"R.T. Prehn","year":"1957","unstructured":"Prehn, R.T. and Main, J.M. (1957) Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18, 769\u2013778.","journal-title":"J. Natl. Cancer Inst."},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0952-7915(95)80033-6","volume":"7","author":"H.G. Rammensee","year":"1995","unstructured":"Rammensee, H.G. (1995) Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7, 85\u201396.","journal-title":"Curr. Opin. Immunol."},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.iy.11.040193.001241","volume":"11","author":"H.G. Rammensee","year":"1993","unstructured":"Rammensee, H.G., Falk, K. and Rotzschke, O. (1993) Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11, 213\u2013244.","journal-title":"Annu. Rev. Immunol."},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00251-004-0709-7","volume":"56","author":"P.A. Reche","year":"2004","unstructured":"Reche, P.A., Glutting, J.P., Zhang, H. and Reinherz, E.L. (2004) Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 56, 405\u2013419.","journal-title":"Immunogenetics"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1084\/jem.183.3.1185","volume":"183","author":"P.F. Robbins","year":"1996","unstructured":"Robbins, P.F., El-Gamil, M., Li, Y.F., Kawakami, Y., Loftus, D., Appella, E. and Rosenberg, S.A. (1996) A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183, 1185\u20131192.","journal-title":"J. Exp. Med."},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","volume":"175","author":"S.A. Rosenberg","year":"2005","unstructured":"Rosenberg, S.A., Sherry, R.M., Morton, K.E., Scharfman, W.J., Yang, J.C., Topalian, S.L., Royal, R.E., Kammula, U., Restifo, N.P., Hughes, M.S., Schwartzentruber, D., Berman, D.M., Schwarz, S.L., Ngo, L.T., Mavroukakis, S.A., White, D.E. and Steinberg, S.M. (2005) Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8+ T cells in patients with melanoma. J. Immunol. 175, 6169\u20136176.","journal-title":"J. Immunol."},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/348252a0","volume":"348","author":"O. Rotzschke","year":"1990","unstructured":"Rotzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G. and Rammensee, H.G. (1990) Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348, 252\u2013254.","journal-title":"Nature"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1002\/eji.1830211136","volume":"21","author":"O. Rotzschke","year":"1991","unstructured":"Rotzschke, O., Falk, K., Stevanovic, S., Jung, G., Walden, P. and Rammensee, H.G. (1991) Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21, 2891\u20132894.","journal-title":"Eur. J. Immunol."},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.0.CO;2-K","volume":"28","author":"E. Sadovnikova","year":"1998","unstructured":"Sadovnikova, E., Jopling, L.A., Soo, K.S. and Stauss, H.J. (1998) Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. Eur. J. Immunol. 28, 193\u2013200.","journal-title":"Eur. J. Immunol."},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"13114","DOI":"10.1073\/pnas.93.23.13114","volume":"93","author":"E. Sadovnikova","year":"1996","unstructured":"Sadovnikova, E. and Stauss, H.J. (1996) Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 93, 13114\u201313118.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/sj.leu.2402635","volume":"16","author":"E. Sadovnikova","year":"2002","unstructured":"Sadovnikova, E., Parovichnikova, E.N., Savchenko, V.G., Zabotina, T. and Stauss, H.J. (2002) The CD68 protein as a potential target for leukaemia-reactive CTL. Leukemia 16, 2019\u20132026.","journal-title":"Leukemia"},{"key":"14_CR36","first-page":"833","volume":"39","author":"F.E. Sharkey","year":"1979","unstructured":"Sharkey, F.E. and Fogh, J. (1979) Incidence and pathological features of spontaneous tumors in athymic nude mice. Cancer Res. 39, 833\u2013839.","journal-title":"Cancer Res."},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevImmunol.v18.i1-2.60","volume":"18","author":"L.A. Sherman","year":"1998","unstructured":"Sherman, L.A., Theobald, M., Morgan, D., Hernandez, J., Bacik, I., Yewdell, J., Bennink, J. and Biggs, J. (1998) Strategies for tumor elimination by cytotoxic T lymphocytes. Crit. Rev. Immunol. 18, 47\u201354.","journal-title":"Crit. Rev. Immunol."},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrc1669","volume":"5","author":"A.J. Simpson","year":"2005","unstructured":"Simpson, A.J., Caballero, O.L., Jungbluth, A., Chen, Y.T. and Old, L.J. (2005) Cancer\/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 5, 615\u2013625.","journal-title":"Nat. Rev. Cancer"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1002\/eji.200636539","volume":"36","author":"D. Sommermeyer","year":"2006","unstructured":"Sommermeyer, D., Neudorfer, J., Weinhold, M., Leisegang, M., Engels, B., Noessner, E., Heemskerk, M.H., Charo, J., Schendel, D.J., Blankenstein, T., Bernhard, H. and Uckert, W. (2006) Designer T cells by T cell receptor replacement. Eur. J. Immunol. 36, 3052\u20133059.","journal-title":"Eur. J. Immunol."},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.coi.2004.09.009","volume":"16","author":"M.A. Su","year":"2004","unstructured":"Su, M.A. and Anderson, M.S. (2004) Aire: an update. Curr. Opin. Immunol. 16, 746\u2013752.","journal-title":"Curr. Opin. Immunol."},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF02785868","volume":"16","author":"I.M. Svane","year":"1999","unstructured":"Svane, I.M., Boesen, M. and Engel, A.M. (1999) The role of cytotoxic T lymphocytes in the prevention and immune surveillance of tumors - lessons from normal and immunodeficient mice. Med. Oncol. 16, 223\u2013238.","journal-title":"Med. Oncol."},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/eji.1830260827","volume":"26","author":"I.M. Svane","year":"1996","unstructured":"Svane, I.M., Engel, A.M., Nielsen, M.B., Ljunggren, H.G., Rygaard, J. and Werdelin, O. (1996) Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice. Eur. J. Immunol. 26, 1844\u20131850.","journal-title":"Eur. J. Immunol."},{"key":"14_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1034\/j.1600-065X.2002.18806.x","volume":"188","author":"P. Van Der Bruggen","year":"2002","unstructured":"Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E.S., Chapiro, J., Van Den Eynde, B.J., Brasseur, F. and Boon, T. (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol. Rev. 188, 51\u201364.","journal-title":"Immunol. Rev."},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/eji.1830261132","volume":"26","author":"F. Vartdal","year":"1996","unstructured":"Vartdal, F., Johansen, B.H., Friede, T., Thorpe, C.J., Stevanovic, S., Eriksen, J.E., Sletten, K., Thorsby, E., Rammensee, H.G. and Sollid, L.M. (1996) The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur. J. Immunol. 26, 2764\u20132772.","journal-title":"Eur. J. Immunol."},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/intimm\/4.10.1085","volume":"4","author":"H.J. Wallny","year":"1992","unstructured":"Wallny, H.J., Deres, K., Faath, S., Jung, G., Van Pel, A., Boon, T. and Rammensee, H.G. (1992b) Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int. Immunol. 4, 1085\u20131090.","journal-title":"Int. Immunol."},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/eji.1830220307","volume":"22","author":"H.J. Wallny","year":"1992","unstructured":"Wallny, H.J., Rotzschke, O., Falk, K., Hammerling, G. and Rammensee, H.G. (1992a) Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing. Eur. J. Immunol. 22, 655\u2013659.","journal-title":"Eur. J. Immunol."},{"key":"14_CR47","first-page":"3851","volume":"50","author":"P.L. Ward","year":"1990","unstructured":"Ward, P.L., Koeppen, H.K., Hurteau, T., Rowley, D.A. and Schreiber, H. (1990) Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+T cell-dependent surveillance. Cancer Res. 50, 3851\u20133858.","journal-title":"Cancer Res."},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0198-8859(02)00730-9","volume":"64","author":"R.A. Willemsen","year":"2003","unstructured":"Willemsen, R.A., Debets, R., Chames, P. and Bolhuis, R.L. (2003) Genetic engineering of T cell specificity for immunotherapy of cancer. Hum. Immunol. 64, 56\u201368.","journal-title":"Hum. Immunol."},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.molimm.2003.11.022","volume":"40","author":"D.B. Wilson","year":"2004","unstructured":"Wilson, D.B., Wilson, D.H., Schroder, K., Pinilla, C., Blondelle, S., Houghten, R.A. and Garcia, K.C. (2004) Specificity and degeneracy of T cells. Mol. Immunol. 40, 1047\u20131055.","journal-title":"Mol. Immunol."},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.7652577","volume":"269","author":"T. Wolfel","year":"1995","unstructured":"Wolfel, T., Hauer, M., Schneider, J., Serrano, M., Wolfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Buschenfelde, K.H. and Beach, D. (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281\u20131284.","journal-title":"Science"},{"key":"14_CR51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/bjc.1985.25","volume":"51","author":"M.F. Woodruff","year":"1985","unstructured":"Woodruff, M.F. and Hodson, B.A. (1985) The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas I. Tumorigenicity and immunogenicity. Br. J. Cancer 51, 161\u2013169.","journal-title":"Br. J. Cancer"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0022-1759(02)00196-5","volume":"268","author":"X.N. Xu","year":"2002","unstructured":"Xu, X.N. and Screaton, G.R. (2002) MHC\/peptide tetramer-based studies of T cell function. J. Immunol. Methods 268, 21\u201328.","journal-title":"J. Immunol. Methods"},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2249.2005.02715.x","volume":"139","author":"S. Xue","year":"2005","unstructured":"Xue, S., Gillmore, R., Downs, A., Tsallios, A., Holler, A., Gao, L., Wong, V., Morris, E. and Stauss, H.J. (2005) Exploiting T cell receptor genes for cancer immunotherapy. Clin. Exp. Immunol. 139, 167\u2013172.","journal-title":"Clin. Exp. Immunol."},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0092-8674(00)81905-4","volume":"88","author":"J. Zerrahn","year":"1997","unstructured":"Zerrahn, J., Held, W. and Raulet, D.H. (1997) The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88, 627\u2013636.","journal-title":"Cell"}],"container-title":["Advances in Experimental Medicine and Biology","Immune-Mediated Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-387-72005-0_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T22:33:25Z","timestamp":1676673205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-0-387-72005-0_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"ISBN":["9780387720043","9780387720050"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-0-387-72005-0_14","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-0-387-72005-0","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}